Skip to content

Insider · CIK 0001874199

Theodore James Washburn Jr.

officer

Files at AGIO (AGIOS PHARMACEUTICALS, INC.). First filing Nov 13, 2024, latest Mar 4, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $180k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

AGIO: AGIOS PHARMACEUTICALS, INC.

AGIOOct 9, 2026 · close 31.81

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
12Weak
AGIOsell 610b5-1
AGIOS PHARMACEUTICALS, INC.
$59k
1,655 shares
-26%+4% from low-46% from high
0Weak
AGIOsell10b5-1
AGIOS PHARMACEUTICALS, INC.
$78k
2,272 shares
-29%+8% from low-44% from high
46Moderate
AGIOsell 3
AGIOS PHARMACEUTICALS, INC.
$43k
772 shares
-49%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Common stock10b5-1
+777$0.00$06,269Mar 4, 2025
Mar 3, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
SOpen-market sale
Common stock10b5-1
-231$35.54$8,2106,038Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Common stock10b5-1
+2,350$0.00$08,388Mar 4, 2025
Mar 3, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
SOpen-market sale
Common stock10b5-1
-697$35.54$25k7,691Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Common stock10b5-1
+2,450$0.00$010,141Mar 4, 2025
Mar 3, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
SOpen-market sale
Common stock10b5-1
-727$35.54$26k9,414Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AGrant or award
Restricted stock unitsderivative10b5-1
+8,085$0.00$08,085Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AGrant or award
Restricted stock unitsderivative10b5-1
+6,142$0.00$06,142Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Restricted stock unitsderivative10b5-1
-777$0.00$00Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Restricted stock unitsderivative10b5-1
-2,350$0.00$02,350Mar 4, 2025
Mar 3, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Restricted stock unitsderivative10b5-1
-2,450$0.00$04,900Mar 4, 2025
Feb 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Common stock10b5-1
+6,896$0.00$07,709Feb 5, 2025
Feb 5, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
SOpen-market sale
Common stock10b5-1
-2,272$34.39$78k5,437Feb 5, 2025
Feb 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Restricted stock unitsderivative10b5-1
-6,896$0.00$00Feb 5, 2025
Nov 8, 2024AGIO
AGIOS PHARMACEUTICALS, INC.
SOpen-market sale
Common stock
-772$56.09$43k813Nov 13, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Theodore James Washburn Jr.: insider trades and track record | InsiderTell